Advocacy & Alignment
Constructive engagement with regulators, standard-setting bodies, and scientific authorities is the only viable path forward. TIMA provides the unified, evidence-driven voice our industry requires.
Alignment is active participation in the codification of professional standards. It is the deliberate convergence of clinical practitioners, toxicological researchers, and statutory bodies: ensuring that regulatory frameworks are informed by empirical laboratory evidence rather than bureaucratic supposition.
By establishing direct institutional channels with public health agencies, TIMA transforms compliance from an adversarial mandate into a shared scientific discipline.
FDA-APPROVED PIGMENTS FOR INJECTION INTO HUMAN DERMIS
SUBSTANCES RESTRICTED UNDER EU REACH ANNEX XVII REGULATION
THE COSMETIC STATUTE STILL BEING USED TO REGULATE MODERN INKS
PEER-REVIEWED EVIDENCE ESTABLISHING TATTOOING IS NOT INJECTION
Delivering rigorous institutional representation through direct regulatory dialogue, technical translation, and evidence-driven consensus frameworks.
01
Direct liaison with federal, state, and international health agencies to provide empirical technical data, real-world manufacturing context, and constructive regulatory consultation.
02
Equipping manufacturers, distributors, and certified practitioners with clear compliance roadmaps, technical briefings, and operational readiness frameworks.
03
Publishing authoritative consensus documents, analytical methodology reviews, and formal toxicological positions on raw ingredient safety and threshold limits.
04
Fostering active multilateral alignment across clinical researchers, academic institutions, toxicologists, and professional trade bodies to unify industry standards.
05
Converting intricate statutory language into actionable manufacturing benchmarks, standardized laboratory test regimes, and reproducible quality management systems.
06
Prioritizing consumer protection through traceable ingredient transparency, rigorous microbiological purity standards, and proactive contamination surveillance.
The FDA and leading dermatological authorities distinguish epidermal pigment suspension from systemic hypodermic delivery. Mechanical micro-puncturing deposits insoluble minerals within dermal macrophages without breaching circulatory thresholds.
The Tattoo Industry Manufacturers Alliance (TIMA) formally disputes the use of the term “injection” when describing tattooing or tattoo inks, as it is scientifically and technically inaccurate.
Injection implies the delivery of a liquid substance into the body via pressure-driven force and hollow-bore needle systems designed to deposit material into tissue or circulation.
Tattooing does not meet this definition.
Tattoo machines operate through rapid, shallow, mechanical puncture that creates micro-channels in the skin, allowing pigment dispersions to be deposited within the dermal layer through capillary action and localized tissue interaction—not forced injection.
Conflating tattooing with injection misrepresents the mechanics, materials, and risk profile of the process, leading to regulatory assumptions that do not reflect real-world tattoo practice.
Accurate terminology is essential to developing fair, science-based standards that appropriately address tattoo materials, artist technique, and public health without imposing frameworks designed for unrelated medical or pharmaceutical applications.
Join TIMA to support a unified trade voice, rigorous scientific positioning, and responsible regulatory alignment across the industry.
Trade association participation is open to qualified industry stakeholders and scientific partners.
Receive monthly updates on regulatory changes that matter and practical guidance on what they mean for your business.
TIMA unites tattoo and PMU stakeholders to advance industry-led standards, regulatory alignment, and member education, protecting public safety without sacrificing the craft.
Copyright 2026. Tattoo Industry Manufacturers Alliance. All Rights Reserved.